A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)

NCT06294912 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

OTHER: Plasmodium falciparum
DRUG: MK-7602
DRUG: Artemether/lumefantrine
DRUG: Primaquine
DRUG: Artesunate
DRUG: Atovaquone/proguanil

Sponsor

Merck Sharp & Dohme LLC